Does BioNTech (NASDAQ:BNTX) Have A Healthy Balance Sheet? - simplywall.st
6 days ago • Google News
BioNTech SE (BNTX)
US$ 92.8-2.05%
Price Chart
Key Statistics
Market Cap
$ 26.44B
P/E Ratio
0.00
Revenue (TTM)
$ 2.75B
Volume
1.04M
52W High
$ 131.49
52W Low
$ 76.53
Dividend Yield
0.00%
Beta
1.28
Technicals
50-Day MA
103.2426
200-Day MA
109.4973
52 Week High
131.49
52 Week Low
76.53
About BNTX
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial fo.
Employees
6772
Headquarters
Mainz, Germany
CEO
Dr. Ugur Sahin M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg